Government urged to probe multinational firms over rebate

There are mounting cries that the Korean government should scrutinize the country's multinational drug firms in relation to their suspected undue business practices.

Critics said it could be “problematic'' if foreign-invested companies are left untouched at a time when domestic pharmaceutical companies face punishment for offering rebates to hospitals and wholesalers.

“Many would probably...